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Abstract
Background: The availability of sequence data of human pathogenic fungi generates opportunities to develop
Bioinformatics tools and resources for vaccine development towards benefitting at-risk patients.
Description: We have developed a fungal adhesin predictor and an immunoinformatics database with predicted
adhesins. Based on literature search and domain analysis, we prepared a positive dataset comprising adhesin
protein sequences from human fungal pathogens Candida albicans, Candida glabrata, Aspergillus fumigatus,
Coccidioides immitis, Coccidioides posadasii, Histoplasma capsulatum, Blastomyces dermatitidis, Pneumocystis carinii,
Pneumocystis jirovecii and Paracoccidioides brasiliensis. The negative dataset consisted of proteins with high
probability to function intracellularly. We have used 3945 compositional properties including frequencies of mono,
doublet, triplet, and multiplets of amino acids and hydrophobic properties as input features of protein sequences
to Support Vector Machine. Best classifiers were identified through an exhaustive search of 588 parameters and
meeting the criteria of best Mathews Correlation Coefficient and lowest coefficient of variation among the 3 fold
cross validation datasets. The “FungalRV adhesin predictor” was built on three models whose average Mathews
Correlation Coefficient was in the range 0.89-0.90 and its coefficient of variation across three fold cross validation
datasets in the range 1.2% - 2.74% at threshold score of 0. We obtained an overall MCC value of 0.8702
considering all 8 pathogens, namely, C. albicans, C. glabrata, A. fumigatus, B. dermatitidis, C. immitis, C. posadasii, H.
capsulatum and P. brasiliensis thus showing high sensitivity and specificity at a threshold of 0.511. In case of P.
brasiliensis the algorithm achieved a sensitivity of 66.67%. A total of 307 fungal adhesins and adhesin like proteins
were predicted from the entire proteomes of eight human pathogenic fungal species. The immunoinformatics
analysis data on these proteins were organized for easy user interface analysis. A Web interface was developed for
analysis by users. The predicted adhesin sequences were processed through 18 immunoinformatics algorithms and
these data have been organized into MySQL backend. A user friendly interface has been developed for
experimental researchers for retrieving information from the database.
Conclusion: FungalRV webserver facilitating the discovery process for novel human pathogenic fungal adhesin
vaccine has been developed.
Background
As cases of immunosuppression rise, the spectrum of
fungal pathogens is increasing thus posing a serious
threat to human health. In the USA and in most Eur-
opean countries infection due to Candida species have
become very common [1]. Amongst the Candida spp,
C. albicans and C. glabrata account for approximately
70-80% of Candida species recovered from patients with
candidemia or invasive candidiasis [2,3]. Another patho-
genic fungi, A. fumigatus is the most common life-threa-
tening aerial fungal pathogen which primarily affects the
lungs. In severe invasive aspergillosis caused mainly in
immunocompromised individuals, the fungus can trans-
fer from lungs through blood stream to brain and other
organs. This condition of invasive aspergillosis is often
associated with significant mortality and morbidity [4,5].
In addition, certain non-life-threatening superficial and
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fungi like C. immitis, H. capsulatum, P. brasiliensis and
B. dermatitidis impose significant restrictions on
patients, resulting in a reduced quality of life. In some
cases these infections may turn to life threatening
specially in immunocompromised patients, where the
infection spreads beyond the respiratory system to other
parts of the body [6-10]. Another fungal infection Pneu-
mocystis pneumonia (PCP) or pneumocystosis caused by
unusual unicellular fungi Pneumocystis jirovecii (for-
merly called Pneumocystis carinii)i st h em o s tc o m m o n
o p p o r t u n i s t i ci n f e c t i o ni np ersons with HIV infection
[11].
It is challenging to identify candidates for vaccines in
case of fungal infections because of their occurrence in
immunocompromised or otherwise debilitated host. Yet
it is being realized that either a preventive or therapeu-
tic vaccine could be useful for at-risk patients [12,13].
Adhesins are important virulence factors used by
pathogens during establishment of infection. Therefore,
targeting the adhesins in vaccine development can help
efficiently combat fungal infections by blocking their
function and preventing adherence to host cell [14]. A
few vaccine formulations using adhesins as immunizing
agents and are under evaluation include agglutinin-like
sequence proteins in Candida albicans [15,16], BAD-1
(WI adhesin) protein in Blastomyces dermatitidis
[17,18], 43 kDa glycoprotein in Paracoccidioides brasi-
liensis [19,20] and spherule outer wall glycoprotein in
Coccidioides immitis [21,22]. Among these, the spherule
outer wall glycoprotein in Coccidioides immitis has
undergone trial in humans, while others have proved
their efficacy in mouse experimental models.
Most fungal adhesins have a general structure con-
sisting of an N-terminal carbohydrate or peptide-bind-
ing domain, central Ser-Thr rich glycosylated domains
and C-terminal region mediating covalent cross-linking
to the wall through modified glycosylphosphatidylinosi-
t o l( G P I )a n c h o r s[ 2 3 , 2 4 ] .O t h e r ss u c ha sW I - 1 / B a d 1
adhesin (from B. dermatiditis), Int1p adhesin (from C.
albicans) do not conform to this general structure
thereby causing difficulty in their identification. Using
similarity search approach, Weig et al. (2004) and But-
ler et al. (2009) identified adhesins and GPI-anchored
proteins in certain fungal pathogens [25,26]. These
efforts can be complemented using machine learning
techniques trained on compositional properties in the
identification of novel adhesins because in principle,
this approach allows development of a non-homology
composition based method. The similarity based
approach in principle enable identifying members of
related family whereas the non-homology composition
based method has potential to identify other novel
members. Algorithms based on compositional
properties for adhesin identification in different patho-
genic species such as Plasmodium and bacteria have
been useful [27,28], encouraging us to attempt to
develop a similar method for fungal species. Here, we
present an algorithm developed by using Support Vec-
tor Machine trained through a combination of 3945
compositional properties for classifying human patho-
genic fungal adhesins and adhesin like proteins. The
predictions from these algorithms can be integrated
with the immunoinformatics algorithms to facilitate
rational vaccine development using reverse vaccinology
[29,30]. The immunoinformatics data on the predicted
fungal adhesins and adhesin like proteins are also
organized for easy analysis and retrieval. These
resources are made available through a user friendly
interface FungalRV.
Construction and Content
Dataset Preparation
Positive Dataset
Through literature survey we collected known human
pathogenic fungal adhesin protein sequences from
C. albicans, C. glabrata, A. fumigatus, B. dermatitidis,
C. immitis, C. posadasii, H. capsulatum, P. brasiliensis,
P. jirovecii and P. carinii.I nC. glabrata proteins having
PA14 and GLEYA adhesin domain were also included
[31,32]. Sequences were collected from the National
Center for Biotechnology Information (NCBI) [33], Can-
dida Genome Database (CG D )[ 3 4 ]a n dS w i s s - P r o t
Databases [35].
Negative Dataset
Protein sequences which are not likely to be on the sur-
face, or associated with adhesion were collected from
NCBI, CGD and Swiss-Prot using keywords ‘dehydra-
tase’, ‘ribosomal protein’, ‘kinase’, ‘polymerase’, ‘acyl-
CoA synthase’, ‘decarboxylase’,a n d‘hydrolase’. Poorly
annotated sequences were not considered. Pfam domain
search was performed on negative dataset sequences.
The results were analyzed exhaustively and any extracel-
lular location associated domain containing protein
sequence in the negative dataset was excluded. ‘See
additional file 1: Pfam domain search result of negative
dataset’.
Proteomes
Proteomes of freely available fungal pathogens were
sourced from various databases listed in Table 1. [36-38]
Rendering datasets nonredundant
The stringent criterion (S = 100, L = 1, b = T) speci-
fied in the BLASTCLUST computer program was used
to identify redundancy. Redundant entries were
removed using Shell scripts. The final positive dataset
had 101 non redundant adhesin protein sequences and
the negative dataset had 2644 non redundant protein
sequences.
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After several attempts using different combinations of
compositional properties, we finally settled on the
following:
Amino acid frequencies
ﬁ(a) =X i / L
Xi is the counts of i
th amino acid in the sequence, i =
1, ..., 20 for each of the amino acid type and L is the
length of the protein. There are 20 possible values for fi
(a) for 20 amino acids.
Multiplet frequencies
Multiplets are defined as homopolymeric stretches (X)n
where X is the amino acid and n (integer) ≥ 2 [39].
After identification of all the multiplets, the frequencies
of the amino acids in the multiplets were computed as
follows:
ﬁ(m) =X m i /L.
Xmi is the counts of i
th amino acid occurring as mul-
tiplet. There are 20 possible values for fi(m) for each of
the 20 amino acids; and L is the length of the protein.
Dipeptide frequencies
The frequency of a dipeptide (i, j),
ﬁj =

countsofijth dipeptide

∗ 100/(L − 1)

/2,
where i, j = 1...20 for each of the 20 amino acids and
L is the length of the sequence. The best dipeptides dis-
criminators between positive and negative sets were
identified with the help of Welch’s t test in R statistical
software (ver 2.9.2) [40]. Top 247 dipeptides were
selected at cutoff significance at P-value < 0.001.
Tripeptide frequencies
The frequency of a tripeptide (i, j, k),
ﬁjk =

countsofijk
th tripeptide

∗ 100/(L − 2)

/3
where i, j, k = 1-20. The best tripeptides discrimina-
tors between positive and negative sets were identified
with the help of Welch’s t test in R statistical software
(ver 2.9.2) [40]. Top 3653 tripeptides were selected at
cutoff significance at P-value < 0.001.
Hydrophobic Composition
Each amino acid is given a hydrophobicity score
between +4.5 and -4.5 according to Kyte and Doolittle
hydrophobicity scale [41]. A score of +4.5 is the most
hydrophobic and a score of -4.5 is the most hydrophilic.
The hydrophobic amino acids with positive score A, M,
C, F, L, V, I were selected. The frequency of hydropho-
bic amino acids (A, M, C, F, L, V, I) is given by,
fh =

countsofanyofthe7hydrophobicaminoacids

/L
where L is the length of the protein. Furthermore,
information on the characteristics of the distribution of
these amino acids in a given protein sequence was
obtained by computing the moments of the positions of
the occurrences of these amino acids. The general
expression to compute moments of a given order; say ‘r’
is,
Mr = r-th order moment of the positions of hydro-
phobic amino acids
=

(Xi − Xm)
r/N,
Where, Xm =
N
i=1 Xi/N
Xm is the mean of sequence positions of all hydropho-
bic amino acids, Xi i st h es e q u e n c ep o s i t i o no ft h ei
th
hydrophobic amino acid where i is any of the 7 hydro-
p h o b i ca m i n oa c i d sA ,M ,C ,F ,L ,V ,I ;a n dNi st h e
total number of hydrophobic amino acids in the
sequence and r is from 2-5. The values of the r
th order
moments were downscaled to smaller decimal values by
dividing by (1000)
r w h i l ep r e p a r i n gt h ef e a t u r ei n p u tt o
SVM.
Thus, a total of 3945 compositional properties
included amino acid frequencies of 20 from amino
acids, 247 selected dipeptide frequencies, 3653 selected
tripeptide frequencies, 20 amino acid multiplets frequen-
cies, frequency of the hydrophobic amino acids and
moments of hydrophobic amino acid distribution of
order from 2-5.
Each sequence is represented by 3945 features. Pro-
grams in C language were written to calculate these
compositional properties. These compositional
Table 1 List of databases from which the human
pathogenic fungal proteomes were sourced
Species Source Reference
Candida albicans (21
st assembly) Candida Genome
Database
[34,26]
Candida glabrata Genolevures [36,26]
Aspergillus fumigatus J. Craig Venter Institute [37]
Coccidioides immitis RMSCC 2394 Broad Institute [38,26]
Coccidioides posadasii Silveira Broad Institute [38,26]
Histoplasma capsulatum Nam1 Broad Institute [38,26]
Paracoccidioides brasiliensis Pb01 Broad Institute [38,26]
Blastomyces dermatitidis SLH14081 Broad Institute [38,26]
Candida dubliniensis Sanger Institute [26]
Candida tropicalis Broad Institute [38,26]
Candida parapsilosis Broad Institute [38,26]
Candida lusitaniae Broad Institute [38,26]
Candida guilliermondii Broad Institute [38,26]
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ing algorithm SVM.
SVM implementation
SVM is a supervised machine learning algorithm first
introduced by Vapnik [42] used for problems involving
classification and regression. In this study SVM was
implemented using SVM
light package written and dis-
tributed by Thorsten Joachims [43]. This package has
two modules svm_learn and svm_classify.
svm_learn: svm_learn is used prepare models(classi-
fiers) built by learning from the training sets- positively
and negatively labeled datasets labeled +1 and -1
respectively.
svm_classify: svm_classify is used by the models(classi-
fiers) generated by svm_learn to classify the test set
sequences (labeled 0).
Training and Testing process
The model (classifiers) are built using svm_learn module
of SVM
light. The training set was a file containing posi-
tively and negatively labeled samples labeled +1 and -1
respectively mixed in alternating order. Each positive
sample corresponding to a positive protein sequence
had +1 label followed by 3945 compositional properties.
Similarly each negative sample has -1 label followed by
3945 compositional properties.
We have used two types of kernel functions, the poly-
nomial function and the radial basis function (RBF). For
polynomial kernel, all the SVM parameters were set to
default, except d and C, the trade-off between training
error and margin. The scalable memory parameter (m)
was fixed to 120. The values for d and C were incre-
mented stepwise through a combination of 1, 2, 3, 4. . .
t o...9f o rd ,a n d1 0
-5 t o ... 1 0
15 for C. For the RBF
kernel, the parameter gamma g and C were incremented
stepwise through a combination of 10
-15 to . . .10
3 for g,
and 10
-5 to. . .10
15 for C. Svm_light was provided with
these parameters along with the input training set and
by varying these parameter values total 588 models are
generated.
Subsequently each model was input to svm_classify
to classify the test set sequences. The test set is a file
containing positively and negatively labeled samples
labeled 0 mixed in alternating order. The 3945 fea-
tures of these samples were classified and the result is
a numerical value for every sample. This numerical
value above set threshold value of 0.0 is indicative of
the sequence being classified as positive label or nega-
t i v e .T h i sp r e d i c t i o ni sc o m p a r e dt oo u rk n o w n
knowledge of test set and performance of the model is
evaluated.
Threefold Cross Validation
In order to obtain good performing models, threefold
cross validation was done. Both positive and negative
datasets were randomized 1000 times and divided into
three parts, each having nearly equal number of pro-
teins. The positive and negative subsets were merged
to obtain three subsets. Then training and testing is
conducted three times, each time using two subsets for
training and the remaining third set for testing. Thus,
each time, the testing is done on those proteins that
a r en o tap a r to ft h et r a i n i n gs e t( F i g u r e1 ) .T h e
assessment results of each test was carried out by com-
puting the Mathews Correlation Coefficient (MCC
values) [44] for each set of parameters, averaged over
the three test sets and ranked in descending order of
average MCC.
Performance evaluation
To evaluate the performance of the algorithm, specificity
(SP), sensitivity (SN), accuracy (ACC) and MCC were
computed as per the following formulas:
SP=T P /(TP + FP)
SN=T P /(TP + FN)
Accuracy given by
TP + TN
TP+T N +F P+F N
MCC given by
(TP ∗ TN) − (FP ∗ FN)
√
(TN + FN)(TN + FP)(TP + FN)(TP + FP)
where TP is true positives; TN is true negatives; FP is
false positives; FN is false negatives.
All evaluations were carried out at a base cutoff value
of 0.0 as discriminator between positive and negative
samples. This entire process was automated using perl
scripts. Subsequently, coefficient of variation (CV) of
MCC of each model across the three subsets was also
calculated. In the next step, the models were arranged
in descending order of MCC in each of the three sub-
sets and the models with high average MCC value
[0.831-0.919 (maximum)] and low CV (≤5%) were
shortlisted.
Performance Check on Human pathogenic fungal species
The performance of each of these shortlisted models
was evaluated on the entire proteomes of the eight fun-
gal pathogens by testing their ability to identify known
adhesins. We finally selected the best three models for
the “Fungal RV adhesin predictor”. These models along
with the parameters are listed in Table 2. The final
score is defined as Fprediction given by max{score
(F470a)∪score(F470b)∪ score(F449c)} where max means
maximum value in the expression. This produced mini-
mal false positives.
Chaudhuri et al. BMC Genomics 2011, 12:192
http://www.biomedcentral.com/1471-2164/12/192
Page 4 of 14Receiver operating characteristic Curve
The Receiver operating characteristic Curve (ROC
curve) was made from the result of “FungalRV adhesin
predictor” run on the proteomes of eight human fungal
pathogens. Proteins above the default threshold score of
0.0 were examined. Known adhesins were marked as
true positives while proteins with probability to function
intracellularly were marked false positives. The R soft-
ware package ROCR was used to make the ROC curve
[45]. The best threshold inferred from the ROC curve is
0.873. However we observed that this is too stringent
and may miss prediction of many adhesins. Therefore
the next point in ROC curve at threshold value of 0.511
was selected. Using this threshold, the algorithm is able
to achieve a sensitivity of 100% for all human pathogens
except in P. brasiliensis wherein a sensitivity of 66.67%
was achieved. The overall MCC value of 0.8702 was
achieved considering all 8 pathogens (Figure 2, Table 3).
Figure 1 Support Vector Machine (SVM) run flowchart. SVM was trained and tested following this flow process, and the best classifiers were
selected.
Table 2 Parameter Sets and Performances of three Selected Models to Identify Fungal Adhesins and Adhesin-Like
Proteins in human pathogenic fungal species
Best
model(classifier)
selected
Kernel
Type
Parameters Performance of best
model (MCC) in the
selected subset
Mean MCC for
parameters accoss
three subsets
CV for parameters
accross three
subsets
Accuracy
470a RBF g = 0.01
C = 100
0.9189 0.8981 2.74% 99.45%
470b RBF g = 0.01
C = 100
0.9044 0.8981 2.74% 99.34%
449c RBF g = 0.001
C = 100
0.8876 0.8922 1.20% 99.23%
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Though our server focuses on human fungal pathogens
adhesin prediction, we also checked its performance on
a test set of fungal species not pathogenic for human.
This test set of proteins was prepared from the Swiss-
Prot and the NCBI database by using search keywords
“fungi” and “adhesin”, ‘’flocculin”, “agglutinin”.A f t e r
removing the sequences corresponding to the human
fungal pathogens we obtained 74 sequences from Pichia
spp, Debaryomyces spp, Saccharomyces spp, Lachancea
spp, Schizosaccharomyces spp, Kluyveromyces spp, Zygo-
saccharomyces spp, Neosartorya spp, Talaromyces spp,
Botryotinia spp, Nectria spp, Metarhizium spp, Verticil-
lium spp, Emericella spp, Vanderwaltozyma spp, Beau-
veria spp, Trichoderma spp, and Magnaporthe spp.I n
this case, a different combination of models of high
MCC and low coefficient of variation appear appropriate
i ni d e n t i f y i n g6 1o f7 4a d h e s i n sa n dt h u sg i v i n gah i g h
sensitivity of 82.43%. The Fprediction for this case is given
by max{score(F26a)score(F470b)s c o r e ( F 6c)} where max
means maximum value in the expression. These models
along with their parameters are listed in Table 4.
Immunoinformatics Data
Database architecture
Protein sequences of known fungal vaccine candidates
and of 307 predicted adhesins and adhesin like proteins
were analyzed with 18 immunoinformatics algorithms
displayed in Table 5. The ORF identification tags (ORF
ID) assigned to proteins of fungal pathogens as given in
the respected database repositories mentioned earlier
were used as primary keys.
Web Interface
The Webserver is built on Apache version 2.0. Server
side scripting was done in PHP version 5.1.4. The pro-
grams running at back-end for compositional property
calculation are written in C programming language.
These C programs were compiled using the GNU gcc
compiler 3.4.3 in the Itanium 2, 64-bit dual processor
server running on Red Hat Linux Enterprise version 4.
The client side scripting was prepared in HTML and
AJAX. FungalRV can be best viewed with Mozilla Fire-
fox and Internet Explorer. The database was developed
using MySQL version 4.1.20 at back end and runs in
Red Hat Enterprise Linux ES release 4. The database
web interfaces have been developed in HTML and PHP
5.1.4, which dynamically execute the MySQL queries to
fetch the stored data and is run through Apache2 server.
FungalRV web server has these tabs- “Adhesin Predic-
tor”, “Immunoinformatics Data”, “Known Vaccines”,
“Download” and “Help”.T h e“Adhesin Predictor” tab
provides an interface where the users can paste or
upload their query sequences and predict whether the
protein sequence is a fungal adhesin (Figure 3). Users
have the facility to set their own desired threshold cutoff
value. The result can be exported as tab delimited text
file by the users. The facility to search for fungal specific
GPI pattern in the predicted adhesins and adhesin like
proteins using fuzzpro program of EMBOSS has been
Figure 2 Receiver operating characteristic curve.T h es e l e c t e d
optimal threshold value (marked by arrow) for “FungalRV adhesin
predictor” is shown.
Table 3 Summary of predictions by FungalRV adhesin predictor using optimal threshold of 0.511
Species Number of Proteins
above threshold
Number of Known
Adhesins in proteome
Number of adhesins
identified (Sensitivity)
Number of hypothetical
Proteins
Number of false
positives
A. fumigatus 38 2 2(100%) 20 0
C. albicans 81 14 14(100%) 0 1
C. glabrata 62 20 20(100%) 0 0
B. dermatitidis 33 1 1(100%) 10 2
C. immitis 23 1 1(100%) 8 0
C. posadasii 27 1 1(100%) 13 1
H. capsulatum 21 1 1(100%) 6 1
P. brasiliensis 27 3 2(66.67%) 11 0
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Proteins in other fungi (not pathogenic to human)
Best model(classifier)
selected
Kernel Type Parameters Performance of best model (MCC)
in the selected subset
Mean MCC for parameters
accoss three subsets
CV for parameters
accross three subsets
26a polynomial d = 2
c = 0.1
0.9019 0.89 3.24%
470b RBF g = 0.01
c = 100
0.9044 0.8981 2.74%
6c polynomial d = 1
c=1
0.9044 0.8945 0.9%
Table 5 Algorithms used to analyse predicted adhesins for Immunoinformatics
Algorithm Principle Reference
1. BLASTCLUST Clusters protein or DNA sequences based on pairwise matches found using the BLAST algorithm
in case of proteins or Mega BLAST algorithm for DNA.
[60]
2. OrthoMCL OrthoMCL software was used to cluster proteins based on sequence similarity, using an all-
against-all BLAST search of each species’ proteome, followed by normalization of inter-species
differences, and Markov clustering.
[61]
3. BetaWrap Predicts the right-handed parallel beta-helix supersecondary structural motif in primary amino
acid sequences by using beta-strand interactions learned from non-beta-helix structures.
[62]
4. Antigenic Predicts potentially antigenic regions of a protein sequence, based on occurrence frequencies of
amino acid residue types in known epitopes.
[63]
5. TargetP1.1 Predicts the subcellular location of eukaryotic proteins based on the predicted presence of any
of the N-terminal presequences: chloroplast transit peptide (cTP), mitochondrial targeting
peptide (mTP) or secretory pathway signal peptide (SP).
[64]
5. SignalP 3.0 Predicts the presence and location of signal peptide cleavage sites in amino acid sequences
from different organisms. The method incorporates a prediction of cleavage sites and a signal
peptide/non-signal peptide prediction based on a combination of several artificial neural
networks and hidden Markov models.
[65]
6. TMHMM Server v. 2.0 Predicts the transmembrane helices in proteins based on Hidden Markov Model. [66]
7. Conserved Domain Database and
Search Service, v2.22
The Database is a collection of multiple sequence alignments for ancient domains and full-
length proteins. It is used to identify the conserved domains present in a protein query
sequence.
[67]
8. BlastP It uses the BLAST algorithm to compare an amino acid query sequence against a protein
sequence database.
[68]
9. ABCPred Predict B cell epitope(s) in an antigen sequence, using artificial neural network. [69]
10. BcePred Predicts linear B-cell epitopes, using physico-chemical properties. [70]
11. Discotope 1.2 Predicts discontinuous B cell epitopes from protein three dimensional structures utilizing
calculation of surface accessibility (estimated in terms of contact numbers) and a novel epitope
propensity amino acid score.
[71]
12. BEPro BEPro, uses a combination of amino-acid propensity scores and half sphere exposure values at
multiple distances to achieve state-of-the-art performance.
[72]
13. Propred Predicts MHC Class-II binding regions in an antigen sequence, using quantitative matrices
derived from published literature. It assists in locating promiscous binding regions that are useful
in selecting vaccine candidates.
[73]
14. IEDB-AR (Average Relative Binding
Method)
Predicts IC(50) values allowing combination of searches involving different peptide sizes and
alleles into a single global prediction.
[74,75]
15. Bimas Ranks potential 8-mer, 9-mer, or 10-mer peptides based on a predicted half-time of dissociation
to HLA class I molecules. The analysis is based on coefficient tables deduced from the published
literature by Dr. Kenneth Parker, Children’s Hospital Boston.
[76]
16. NetMHC 3.0 Predicts binding of peptides to a number of different HLA alleles using artificial neural networks
(ANNs) and weight matrices.
[77]
17. AlgPred Predicts allergens in query protein based on similarity to known epitopes, searching MEME/MAST
allergen motifs using MAST and assign a protein allergen if it have any motif, search based on
SVM modules and search with BLAST search against 2890 allergen-representative peptides
obtained from Bjorklund et al 2005 and assign a protein allergen if it has a BLAST hit.
[78]
18. Allermatch Predicts the potential allergenicity of proteins by bioinformatics approaches as recommended by
the Codex alimentarius and FAO/WHO Expert consultation on allergenicity of foods derived
through modern biotechnology.
[79]
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facility to conduct BLAST search with human reference
proteins.
On clicking the “Immunoinformatics Data” tab, users
are directed to the FungalRV database of predicted fun-
gal adhesins and adhesin likep r o t e i n s( F i g u r e4 ) .H e r e
users can search the database for adhesin proteins and
their attributes corresponding to one or more ORF
identification tags of a species or against a specific key-
word. Advanced search facility of predicted fungal adhe-
sins is also provided where the results can be filtered on
the basis of protein length, number of transmembrane
spanning regions, localization and reliability class, pre-
sence or absence of betawraps, paralogs, hits to Con-
served Domain Database and Human Reference proteins
(retrieved from NCBI through ftp on 7 August, 2010).
The results obtained can be exported by the user as a
text file in both processes.
The “Known Vaccines” tab takes user to the page con-
taining the list of known vaccine candidates provided in
tabular form.
Utility and Discussion
Adhesin prediction for human fungal pathogens
User interface -
A user friendly interface was developed for using the
“Fungal RV adhesin predictor” algorithm. Users can
paste the sequence in FASTA format or even upload a
file. A threshold of 0.511 was set as the optimal thresh-
old (Figure 2). However, users can set a threshold of
their own choice. The results are displayed in a colour
coded tabular format. ‘See additional file 2: Adhesins
and adhesin like proteins predicted by “FungalRV adhe-
sin predictor” in 8 human fungal pathogens’. Results can
be exported in tab delimited text format.
Our algorithm “FungalRV adhesin predictor” predicted
many cell surface GPI anchored proteins as novel adhe-
sins from the 8 fungal pathogens. ‘See additional file 3:
GPI anchored proteins predicted as adhesin by Fun-
galRV adhesin Predictor’. GPI anchor proteins in fungi
are known to be either covalently incorporated into the
cell wall network or remain attached to the plasma
membrane. The predicted amino acid sequences of GPI
Figure 3 FungalRV adhesin predictor Web site. Users can paste or upload sequences in FASTA format for human pathogenic fungal adhesin
and adhesin-like proteins prediction.
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has a hydrophobic signal sequence that directs the pro-
tein to the ER and their C-termini has a second hydro-
phobic domain, which is cleaved off and replaced with a
GPI anchor (a preformed lipid in the membrane of the
endoplasmic reticulum) by a transamidase enzyme com-
plex. The GPI anchored proteins are linked to plasma
membrane via this preformed GPI anchor [48]. These
proteins may have roles in cell wall biosynthesis, cell
wall remodeling, determining surface hydrophobicity
and antigenicity and in adhesion and virulence [49,50].
In C. albicans “FungalRV adhesin predictor” predicted
proteins proposed to be involved in the process of adhe-
sion to host such as SUN41, IFF4 [51,52]. These pro-
teins were not included in the training set due to
absence of evidence on their direct involvement in adhe-
sion process. However, theire v e n t u a lp r e d i c t i o na s
adhesins by “FungalRV adhesin predictor” suggests their
potential role in mediating adhesion. “FungalRV adhesin
predictor” at optimal threshold of 0.511 predicts all the
members of ALS and Hyr/iff (GPI family 17 and 18),
proposed to be involved in modulating adhesion and
biofilm formation in C. albicans [26]. The ALS family
in C. albicans is characterized as the main class of adhe-
sins [53,54]. Another protein RBT1 showing similarity to
HWP1 and may have adhesion property [55] is also pre-
dicted by “FungalRV adhesin predictor”.
In C. glabrata, several proteins showing similarity to
flocculins and STA1 glucoamylase homologue of S. cere-
visiae were predicted. ‘See additional file 4: Predicted
adhesins from C. glabrata with similarity to either floc-
culins or STA1’. The flocculins are involved in adhesion
process in S. cerevisiae [56,57] and therefore it is prob-
able that these proteins have functional similarity in
their role as adhesins in C. glabrata as well. When com-
pared to the predicted in-silico adhesins by Weig et al
[25], the new release of C. glabrata proteome by Geno-
levures (Sep. 2009) retains 28 orfids of the 51 orfids pre-
dicted as adhesins in the older proteome release by
Genolevures (June 2004). “FungalRV adhesin predictor”
could predict 24 of the 28 in-silico predicted adhesins at
optimal threshold value of 0.511. ‘See additional file 5:
Figure 4 FungalRV Immunoinformatics Web site. Users can query FungalRV Immunoinformatics database for data useful from reverse
vaccinology point of view corresponding to the predicted 307 adhesin and adhesin like proteins and known vaccine candidates.
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dicted adhesins by Weig et al’.
ClustalW [58] analysis among the 307 predicted
adhesin and adhesin like proteins obtained from “Fun-
galRV adhesin predictor” r u no ne n t i r ep r o t e o m e so f
eight human pathogenic fungal species showed that
most (99.65%) of the predicted adhesin sequence pairs
have ClustalW score in the range of 0-35% (Figure 5).
T h e s ed a t as h o wt h a t“FungalRV adhesin predictor”
could predict adhesin sequences from diverse fungal
pathogens thereby attesting its non-homology
characteristic.
“FungalRV adhesin predictor” run on proteomes of
some of the human pathogenic fungi with low inci-
dence of occurrence- Candida dubliniensis, Candida
tropicalis, Candida parapsilosis, Candida lusitaniae
and Candida guilliermondii h a sb e e np r o v i d e da ss u p -
plementary data. ‘See additional file 6: Adhesins and
adhesin like proteins predicted by “FungalRV adhesin
predictor” in other pathogenic fungi with low occur-
rence of incidence’.
Our algorithm FungalRV adhesin predictor uses highly
accurate SVM models (greater than 99%) and therefore
it achieves a good MCC of 0.8702 at a positive threshold
of 0.511 in comparison to FAAPred [59], which uses
SVM models of lower accuracy (86%) and achieves a
MCC of 0.610 at a relatively high negative threshold of
-0.8. FAAPred misses identifying integrins (a class of
known adhesins) from C. albicans and P. carinii and in
some cases identifies known adhesins with low score in
the range (-0.06 to - 0.74) indicating low confidence
predictions in contrast to our algorithm.
Immunoinformatics Database
The FungalRV immunoinformatics database houses
immunoinformatics data on 307 predicted adhesins and
adhesin like proteins obtained by “FungalRV adhesin
predictor” run on entire proteomes of eight human
pathogenic fungal species. This includes 80 from C.
albicans,6 2f r o mC. glabrata,3 8f r o mA. fumigatus,3 1
from B. dermatitidis,2 7f r o mP. brasiliensis,2 0f r o mH.
capsulatum,2 3f r o mC. immitis and 26 from C. posada-
sii. The database houses detailed information on pro-
teins analysed through 18 algorithms important from
the view of reverse vaccinology (Table 5) [60-79]. The
analysis through these algorithms provide a broad range
of information regarding Orthologs, Paralogs, Beta-
Wraps, Localization, Transmembrane spanning regions,
Figure 5 Number of Sequence Pairs in the shown ClustalW score (percent Identity) ranges. This graph was plotted for the 307 predicted
fungal adhesins and adhesin like protein sequences from the selected eight human pathogenic fungal species. This data includes sequences
from the training set.
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Page 10 of 14Signal Peptides, Conserved domains, similarity to
Human Reference Proteins, T-cell epitopes, B-cell epi-
topes, Discotopes, and Allergen predictions. The overall
layout of FungalRV is provided in Figure 6
First level of searching and retrieval of data is possible
either through ORF ID or keywords. Multiple ORF IDs
can be submitted using comma separation. Keywords
can be used singly. If multiple keywords are used then
the search is implemented using the AND Boolean. In
the case of searching for epitope data, due to their huge
size, data are conveniently retrieved in a singular mode
for each ORF ID specifically. All data can be exported
conveniently as a text file.
Conclusion
A Web server aiding in novel human pathogenic fungal
adhesin vaccine prediction and development has been
prepared [80].
Availability and Requirement
Sever can be accessed at http://fungalrv.igib.res.in. The
server is best viewed with Explorer 8.0 or later and
Mozilla firefox version 3.0 or later
Additional material
Additional file 1: Pfam Domain Search Result of negative dataset.
The file presents Pfam domain search result on negative training set.
Additional file 2: Adhesins and adhesin like proteins predicted by
FungalRV adhesin Predictor in 8 human fungal pathogens. The file
lists 307 adhesins and adhesin like proteins obtained by “FungalRV
adhesin predictor” run on entire proteomes of eight human pathogenic
fungal species along with their FungalRV adhesin predictor scores.
Known adhesins are coloured in Green.
Additional file 3: GPI anchored proteins predicted as adhesin by
FungalRV adhesin predictor. FungalRV adhesin predictor predicted
many cell surface GPI anchored proteins as novel adhesins. These
proteins along with their FungalRV adhesin predictor score are listed in
this file.
Figure 6 Overall FungalRV Layout: The proteomes of eight human pathogenic fungal species listed in the diagram were run through
“FungalRV adhesin predictor” obtaining a list of 307 fungal adhesins and adhesin like proteins. The diagram provides a layout of analysis
of the predicted proteins. All data are organized in relation to the primary key ORF ID. The analysis data obtained was arranged into FungalRV
Database providing users’ facility to query and export results into tab delimited text format.
Chaudhuri et al. BMC Genomics 2011, 12:192
http://www.biomedcentral.com/1471-2164/12/192
Page 11 of 14Additional file 4: Predicted adhesins from Candida glabrata with
similarity to either flocculins or STA1. Predicted adhesins from
Candida glabrata with similarity to either flocculins or STA1 by “FungalRV
adhesin predictor” along with their “FungalRV adhesin predictor” scores
are listed in this file.
Additional file 5: “FungalRV adhesin predictor” scores of In-silico
predicted adhesins by Weig et al. “FungalRV adhesin predictor” scores
of In-silico predicted adhesins by Weig et al. are listed in this file.
Additional file 6: Adhesins and adhesin like proteins predicted by
“FungalRV adhesin predictor” in other pathogenic fungi with low
incidence of occurrence. The file lists adhesins and adhesin like
proteins obtained by “FungalRV adhesin predictor” run on entire
proteomes of some of the human pathogenic fungi with low incidence
of occurrence along with their FungalRV adhesin predictor scores.
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